Posts

As I reflect on PCORI’s accomplishments in 2023, I see so much to celebrate, and so much to build on in the year ahead. As the leading funder of patient-centered…

WASHINGTON, D.C. — The Patient-Centered Outcomes Research Institute (PCORI) today began inviting proposals for new studies and projects through 10 funding opportunities. Five of these PCORI Funding Announcements (PFAs) are…

WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) today began inviting proposals for new studies and implementation projects through 11 funding opportunities, including the first focused specifically on PCORI…

WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) today began inviting proposals for new studies and implementation projects through nine funding opportunities. These PCORI Funding Announcements (PFAs) include four…

Our nation continues to face urgent health and health care challenges, including rising rates of chronic disease and mental health issues, the crisis of substance use, insufficient access to care…

WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) has opened the application periods for nine funding opportunities that offer up to $308.5 million in total funding. The latest PCORI…

The eighth PCORI Annual Meeting last month highlighted so much of what makes our community special: a broad, diverse range of engaged stakeholders; inspirational expert speakers; compelling results from patient-centered…

WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) this week shared details about a forthcoming $63 million funding opportunity for comparative clinical effectiveness research (CER) studies to reduce inequities…

WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) today began inviting proposals for new studies and implementation projects through nine funding opportunities. These PCORI Funding Announcements (PFAs) include up…

WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) has launched a three-year initiative offering up to $36 million to strengthen and enhance the evidence base on engagement in research…

WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved the development of new research funding opportunities, providing up to $63 million for studies on reducing…

WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) today began accepting proposals for new studies and implementation projects through seven funding opportunities. These PCORI Funding Announcements (PFAs) include a…

WASHINGTON, DC—The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved several slates of funding awards totaling about $71.5 million to support 12 new comparative clinical effectiveness research (CER)…

The new year is often a time for self-reflection and learning—a brief moment of looking back before the revitalizing energy of spring returns to move us forward with renewed energy…

WASHINGTON, DC—Join the Patient-Centered Outcomes Research Institute for a fast-paced, live webinar on February 2 from 1:00 p.m. to 1:30 p.m. to hear an overview of PCORI’s 2022 priorities and…

WASHINGTON, DC—The Patient-Centered Outcomes Research Institute (PCORI) has opened the application periods for eight funding opportunities that offer up to $297.5 million in total funding. The latest PCORI Funding Announcements…

PCORI is always looking for ways to respond to stakeholder feedback and enhance our processes to achieve our mission more effectively. I am pleased to report on some recent and…

WASHINGTON, DC—The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved two slates of research funding awards totaling $49.5 million to support nine new comparative clinical effectiveness research (CER)…

WASHINGTON, DC—The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved an award slate with $32.7 million for a large, multi-phase comparative clinical effectiveness research (CER) study to compare…

People with cardiovascular disease (CVD) taking aspirin to lower their chances of suffering a heart attack or stroke experienced similar health benefits, including reduced death and hospitalization for heart attack and stroke, whether they took a high or low dose of aspirin, according to a study presented today at ACC.21, the American College of Cardiology’s 70th Annual Scientific Session and published in the New England Journal of Medicine.

Emphasizing interest in improving postpartum outcomes for women experiencing disparities in health care, nonsurgical options for women with urinary incontinence, and interventions targeting mental health conditions in people with intellectual and developmental disabilities, the Patient-Centered Outcomes Research Institute (PCORI) today began accepting proposals for research designed to help patients and those who care for them to make better-informed health care decisions.

More than a dozen topics ranging from healthy aging to prevention of drug addiction among adolescents and from telehealth to addressing bias, racism and discrimination throughout the health care continuum will be the focus of efforts to develop future research funding opportunities from the Patient-Centered Outcomes Research Institute (PCORI) following approval at today’s PCORI Board of Governors meeting.

WASHINGTON, DC — Patients, clinicians and families facing uncertainty about their choices for managing Type 2 diabetes and rare diseases will gain new evidence to inform their decision making from…

As 2021 begins, PCORI launches this new year with renewed energy and ambitious goals, inspiring our leadership in patient-centered outcomes research amid challenges that are transforming the nation’s healthcare and…

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today, building on its rapid response to the COVID-19 health crisis, approved allocating up to $50 million in additional funding for new projects in PCORI’s COVID-19 funding opportunities, as well as enhancements to existing PCORI-funded studies. The research will help provide answers to difficult COVID-19 related questions faced by patients, providers and health systems.